Latest Diabetes management Stories

Making assumptions about the similarity of outcomes between laboratory species and humans is often disappointing after much investment of time and cost. Entelos’ ability to explain these phenomena through mechanism-based predictions is revolutionizing a fundamental translational research challenge. San Mateo, CA (PRWEB) June 19, 2012 Metabolism PhysioLab® Used to Compare Rodent to Human Data and Predict How and Why They Differ Entelos, a premier provider of in silico modeling and...

Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a report published Online First by Archives of Neurology, a JAMA Network publication. Findings from previous studies have suggested an association between diabetes mellitus and an increased risk of cognitive impairment and dementia, including Alzheimer disease, but this association...

PARIS, June 19, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, today announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders. The collaboration was unveiled at the 2012 Bio International Convention in Boston, Mass. (LOGO: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO) Building on Joslin's...

PETACH TIKVAH, Israel, June 18, 2012 /PRNewswire/ -- Yet another exciting breakthrough took place yesterday in the advancement and development of the ARTIFICIAL PANCREAS by specialists at Schneider Children's Medical Center of Israel. For the first time ever, two patients with diabetes were successfully treated overnight in their own homes with the MD-Logic Artificial Pancreas (MD-Logic) system. This is a huge and major step towards the development of a commercial...

INDIANAPOLIS, June 18, 2012 /PRNewswire/ -- News Highlights Olympian Kris Freeman visits 10 #diabetes summer #camps; he has shared his #T1 story with nearly 5,000 campers through Lilly's camp program Lilly Diabetes #diabetes #camp tour kicks off on June 20 Lilly Diabetes is one of the largest supporters of #diabetes #camps in the U.S. Many children dream of being a superhero when growing up. To those with diabetes, that is exactly what they see in Kris Freeman....

Diachieve has donated 50,000 glucose tablets to Camp Ho Mita Koda, located near Cleveland, Ohio. The camp’s mission is to help further educate children as to how they can live well with diabetes. Pompano Beach, FL (PRWEB) June 15, 2012 Diachieve has donated 50,000 glucose tabs to Camp Ho Mita Koda, a summer camp located near Cleveland, Ohio whose mission is to enable children to live well with diabetes through an enjoyable camp experience. Camp Ho Mita Koda was founded in 1929 by Dr....

(Ivanhoe Newswire) – In the first systematic review of its kind, new research shows that strictly monitoring blood glucose levels (enhanced glucose control) with the right target levels can prevent diabetic neuropathy. Diabetic neuropathy is a disabling condition that develops in up to half of people with diabetes. It affects the nerves in the feet and legs, making them feel painful, weak, tingly, or numb. It is possible to prevent neuropathy by strictly controlling the blood sugar...

Study reveals new targets for diagnosis and therapy After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. But the reason has long puzzled scientists. Now researchers at Joslin Diabetes Center have identified the misstep that sparks this runaway chronic damage and a promising way to block it. "The problem arises from autoimmunity, a condition that people with type 1 diabetes already have ," says Myra A. Lipes, M.D,...

Study analyses impact of one-off advice session and ongoing support for patients diagnosed with Type 2 diabetes Research led by the University of Leicester concludes that people newly diagnosed with Type 2 diabetes need ongoing advice from GPs sustained over a number of years rather than a one-off session when they are first diagnosed. Although a single programme for people with newly diagnosed Type 2 diabetes mellitus shows sustained improvements in some illness beliefs at three years,...

SEATTLE, June 13, 2012 /PRNewswire/ -- Novo Nordisk (NYSE: NVO) hosted a community event today to celebrate the official opening of Novo Nordisk's new type 1 Diabetes R&D Center in Seattle, which will explore innovative approaches to treat and prevent type 1 diabetes. (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO ) Novo Nordisk, a leader in diabetes care, is the largest global manufacturer of insulin. The new center will combine Novo Nordisk's longstanding...